Alpha Teknova, Inc. Announces the Appointment of Martha J. Demski to Its Board of Directors
August 16, 2023 at 08:00 am
Share
Alpha Teknova, Inc. announced the appointment of Martha J. Demski to its Board of Directors, bringing to the Board more than 35 years of experience in corporate leadership and life sciences business and financial strategies. She will replace Robert McNamara, who has served on the Board since Teknova?s IPO in 2021 and has announced his intention to step down to pursue other opportunities. Both Ms. Demski?s appointment and Mr. McNamara?s resignation will be effective on August 31, 2023.
Ms. Demski was elected to serve on the Company?s Board as an independent Director at its recent quarterly meeting on August 8, 2023. In addition to her role as Director, she will serve as chair of the Board?s Audit Committee and will join its Compensation Committee as a member. In addition to her over 35 years of experience in life sciences companies, Ms. Demski currently serves as the Lead Independent Director on the board of Chimerix, Inc. (CMRX), and as an independent Director on the Equillium, Inc. (EQ) Board of Directors.
She was also recognized as Director of the Year in Corporate Governance by the Corporate Directors Forum.
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
ALPHA TEKNOVA, INC. 
